Terms: = Colorectal cancer AND SYK, P43405, 6850, ENSG00000165025 AND Prognosis
5 results:
1. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of syk gene methylation in colorectal cancer.
Bu F; Zhu X; Liu S; Lin K; Zhu J; Huang J
Immun Inflamm Dis; 2021 Sep; 9(3):923-931. PubMed ID: 33979042
[TBL] [Abstract] [Full Text] [Related]
3. Butyrate-Induced In Vitro Colonocyte Differentiation Network Model Identifies ITGB1, syk, CDKN2A, CHAF1A, and LRP1 as the Prognostic Markers for colorectal cancer Recurrence.
Dasgupta N; Kumar Thakur B; Chakraborty A; Das S
Nutr Cancer; 2019; 71(2):257-271. PubMed ID: 30475060
[TBL] [Abstract] [Full Text] [Related]
4. Inflammatory genes are novel prognostic biomarkers for colorectal cancer.
Jiang H; Dong L; Gong F; Gu Y; Zhang H; Fan D; Sun Z
Int J Mol Med; 2018 Jul; 42(1):368-380. PubMed ID: 29693170
[TBL] [Abstract] [Full Text] [Related]
5. [Association between hypermethylation of syk gene and clinicopathological characteristics in colorectal cancer patients].
Yang ZL; Wang L; Kang L; Peng JS; Xiang J; Huang MJ; Wang JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):458-61. PubMed ID: 18803050
[TBL] [Abstract] [Full Text] [Related]
